Clinical Roundup Korean researchers find CRC patients over 70 years don’t stand to benefit from chemo September 26, 2025Vol.51 No.35
Clinical Roundup Wistar scientists identify novel therapeutic target for ovarian cancer September 26, 2025Vol.51 No.35
Clinical Roundup ALOX15 loss, common in CRC, impairs the cancer-preventative effects of fish oil, mouse study shows September 26, 2025Vol.51 No.35
Drugs & Targets FDA approves Keytruda Qlex injection for subcutaneous use in 38 tumor indications September 26, 2025Vol.51 No.35By Jacquelyn Cobb
Drugs & Targets FDA grants priority review to HER2-directed therapy as first-line treatment of HER2-positive metastatic breast cancer September 26, 2025Vol.51 No.35
NCI Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say September 25, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium September 19, 2025Vol.51 No.34By Paul Goldberg
NCI NCI releases names of members of ad hoc working group—filling the void left by BSA September 19, 2025Vol.51 No.34By Sara Willa Ernst
AACR Cancer Progress Report makes the case for federal investment in cancer research September 19, 2025Vol.51 No.34By Sara Willa Ernst
